| Novartis Pharma Schweiz AG - Lutathera 370 MBq/mL, Infusionslösung | | 69776 | | 01 | | Lutathera 370 MBq/mL | | Infusionslösung | | V10XX04 | | Lutetium (177lu) Oxodotreotide | | 22.11.2024 | | |
| | Composition | | lutetium(177-Lu) oxodotreotidum 370 MBq, acidum aceticum, natrii acetas, acidum gentisicum, E 300, acidum diethylentriamin-pentakis(methylenphosphonicum), natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.24 mg. | | Packungsbestandteile | | Infusion solution | | | | | | Active Agent | Dose |
|---|
| Lutetium(177-Lu) Oxodotreotidum | 370 MBq/ml |
| | | | Inactive agents |
|---|
| Acetic Acid | | Acidum Diethylentriamin-Pentakis(Methylenphosphonicum) | | Acidum Gentisicum | | E 300 | | Sodium Acetate | | Sodium Chloride | | Sodium Hydroxide |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 20 x 1 ml | PR | PR | A | | No |
|
|
